Search research articles
Contact Us
Filters
Showing results (191-200 of 224) with videos related to
Page
of 23
Sort By:
Gynecologic Oncology
|
December 4, 2012
Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies
Kathleen M Schmeler, Ginger L Wilson, Katherine Cain, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 9, 2020
Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges
Katherine I Stewart, Jarrod S Eska, Ross F Harrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2024
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
Pedro T Ramirez, Kristy P Robledo, Michael Frumovitz, et al.
Journal of Oncology Practice
|
October 16, 2019
Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center
Donna S Zhukovsky, Pamela T Soliman, Boby Mathew, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 17, 2024
Molecular image-guided surgery in gynaecological cancer: where do we stand?
Giusi Pisano, Thomas Wendler, Renato A Valdés Olmos, et al.
American Journal of Obstetrics and Gynecology
|
March 12, 2023
Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors
Katherine I Foster, Alejandra Flores Legarreta, Rhea Kamat, et al.
Oncotarget
|
June 14, 2019
Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options
Marilyne Labrie, Tae-Beom Kim, Zhenlin Ju, et al.
Gynecologic Oncology Reports
|
January 15, 2020
Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)
Alessandro D Santin, Virginia Filiaci, Stefania Bellone, et al.
Endocrine-Related Cancer
|
May 15, 2023
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms
Jennifer R Eads, Thorvardur R Halfdanarson, Tim Asmis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 20, 2016
Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases
Priyadharsini Nagarajan, Jonathan L Curry, Jing Ning, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 224) with videos related to
Sort By:
Page
of 23
Gynecologic Oncology
|
December 4, 2012
Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies
Kathleen M Schmeler, Ginger L Wilson, Katherine Cain, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 9, 2020
Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges
Katherine I Stewart, Jarrod S Eska, Ross F Harrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2024
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
Pedro T Ramirez, Kristy P Robledo, Michael Frumovitz, et al.
Journal of Oncology Practice
|
October 16, 2019
Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center
Donna S Zhukovsky, Pamela T Soliman, Boby Mathew, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 17, 2024
Molecular image-guided surgery in gynaecological cancer: where do we stand?
Giusi Pisano, Thomas Wendler, Renato A Valdés Olmos, et al.
American Journal of Obstetrics and Gynecology
|
March 12, 2023
Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors
Katherine I Foster, Alejandra Flores Legarreta, Rhea Kamat, et al.
Oncotarget
|
June 14, 2019
Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options
Marilyne Labrie, Tae-Beom Kim, Zhenlin Ju, et al.
Gynecologic Oncology Reports
|
January 15, 2020
Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)
Alessandro D Santin, Virginia Filiaci, Stefania Bellone, et al.
Endocrine-Related Cancer
|
May 15, 2023
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms
Jennifer R Eads, Thorvardur R Halfdanarson, Tim Asmis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 20, 2016
Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases
Priyadharsini Nagarajan, Jonathan L Curry, Jing Ning, et al.
Page
of 23